Loading…
Primary Hepatocellular Carcinoma With Intense 68Ga-PSMA Uptake But Slight 18F-FDG Uptake on PET/CT Imaging
ABSTRACTGa-PSMA PET/CT imaging is an emerging imaging modality in prostate cancer. PSMA expression is also reported for nonprostate malignancies, including primary hepatocellular carcinoma. Herein, we present a case of a 74-year-ald man with recently diagnosed hepatocellular carcinoma who was referr...
Saved in:
Published in: | Clinical nuclear medicine 2020-03, Vol.45 (3), p.e176-e177 |
---|---|
Main Authors: | , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c2972-8f84eb1f8f47de9aa61f2f122e6f6cc3dee2f6505c15de234bbb3829cf90c6623 |
---|---|
cites | cdi_FETCH-LOGICAL-c2972-8f84eb1f8f47de9aa61f2f122e6f6cc3dee2f6505c15de234bbb3829cf90c6623 |
container_end_page | e177 |
container_issue | 3 |
container_start_page | e176 |
container_title | Clinical nuclear medicine |
container_volume | 45 |
creator | Erhamamci, Seval Aslan, Nesrin |
description | ABSTRACTGa-PSMA PET/CT imaging is an emerging imaging modality in prostate cancer. PSMA expression is also reported for nonprostate malignancies, including primary hepatocellular carcinoma. Herein, we present a case of a 74-year-ald man with recently diagnosed hepatocellular carcinoma who was referred for F-FDG PET/CT imaging for initial staging. The patient underwent F-FDG PET/CT as part of staging procedure; he also underwent Ga-PSMA PET/CT. PET/CT images revealed only slight F-FDG uptake in the liver lesion, but intense Ga-PSMA uptake, without any metastatic lesion seen elsewhere in the body. |
doi_str_mv | 10.1097/RLU.0000000000002922 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2345508777</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2345508777</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2972-8f84eb1f8f47de9aa61f2f122e6f6cc3dee2f6505c15de234bbb3829cf90c6623</originalsourceid><addsrcrecordid>eNqFkE1rGzEQhkVpaZy0_6AUHXvZRBrt6uOYurFjcKlpbHpctPLI3mQ_XElL6L_vGieh9NAKhAb0vDPMQ8gHzi45M-rq-3Jzyf44YABekQkvhMwYgHlNJkxIkRkl4Yycx3jPGJdc5m_JmeBGqVzpCblfhbq14Re9xYNNvcOmGRob6NQGV3d9a-mPOu3pokvYRaRSz222uvt6TTeHZB-Qfh4SvWvq3T5RrmfZ7Mv8-afv6OpmfTVd00Vrd3W3e0feeNtEfP_0XpDN7GY9vc2W3-aL6fUyc2AUZNrrHCvutc_VFo21knvwHACll86JLSJ4WbDC8WKLIPKqqoQG47xhTkoQF-TTqe8h9D8HjKls63hczHbYD7EcI0XBtFJqRPMT6kIfY0BfHk46Ss7Ko-VytFz-bXmMfXyaMFQtbl9Cz1pHQJ-Ax75JGOJDMzxiKPdom7T_X-_8H9EjJthoCRgcK8ay8eZS_AZn2paq</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2345508777</pqid></control><display><type>article</type><title>Primary Hepatocellular Carcinoma With Intense 68Ga-PSMA Uptake But Slight 18F-FDG Uptake on PET/CT Imaging</title><source>HEAL-Link subscriptions: Lippincott Williams & Wilkins</source><creator>Erhamamci, Seval ; Aslan, Nesrin</creator><creatorcontrib>Erhamamci, Seval ; Aslan, Nesrin</creatorcontrib><description>ABSTRACTGa-PSMA PET/CT imaging is an emerging imaging modality in prostate cancer. PSMA expression is also reported for nonprostate malignancies, including primary hepatocellular carcinoma. Herein, we present a case of a 74-year-ald man with recently diagnosed hepatocellular carcinoma who was referred for F-FDG PET/CT imaging for initial staging. The patient underwent F-FDG PET/CT as part of staging procedure; he also underwent Ga-PSMA PET/CT. PET/CT images revealed only slight F-FDG uptake in the liver lesion, but intense Ga-PSMA uptake, without any metastatic lesion seen elsewhere in the body.</description><identifier>ISSN: 0363-9762</identifier><identifier>EISSN: 1536-0229</identifier><identifier>DOI: 10.1097/RLU.0000000000002922</identifier><identifier>PMID: 31977478</identifier><language>eng</language><publisher>United States: Lippincott Williams & Wilkins</publisher><subject>Aged ; Carcinoma, Hepatocellular - diagnostic imaging ; Fluorodeoxyglucose F18 ; Humans ; Liver Neoplasms - diagnostic imaging ; Male ; Membrane Glycoproteins ; Organometallic Compounds ; Positron Emission Tomography Computed Tomography ; Radiopharmaceuticals</subject><ispartof>Clinical nuclear medicine, 2020-03, Vol.45 (3), p.e176-e177</ispartof><rights>Lippincott Williams & Wilkins</rights><rights>Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c2972-8f84eb1f8f47de9aa61f2f122e6f6cc3dee2f6505c15de234bbb3829cf90c6623</citedby><cites>FETCH-LOGICAL-c2972-8f84eb1f8f47de9aa61f2f122e6f6cc3dee2f6505c15de234bbb3829cf90c6623</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31977478$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Erhamamci, Seval</creatorcontrib><creatorcontrib>Aslan, Nesrin</creatorcontrib><title>Primary Hepatocellular Carcinoma With Intense 68Ga-PSMA Uptake But Slight 18F-FDG Uptake on PET/CT Imaging</title><title>Clinical nuclear medicine</title><addtitle>Clin Nucl Med</addtitle><description>ABSTRACTGa-PSMA PET/CT imaging is an emerging imaging modality in prostate cancer. PSMA expression is also reported for nonprostate malignancies, including primary hepatocellular carcinoma. Herein, we present a case of a 74-year-ald man with recently diagnosed hepatocellular carcinoma who was referred for F-FDG PET/CT imaging for initial staging. The patient underwent F-FDG PET/CT as part of staging procedure; he also underwent Ga-PSMA PET/CT. PET/CT images revealed only slight F-FDG uptake in the liver lesion, but intense Ga-PSMA uptake, without any metastatic lesion seen elsewhere in the body.</description><subject>Aged</subject><subject>Carcinoma, Hepatocellular - diagnostic imaging</subject><subject>Fluorodeoxyglucose F18</subject><subject>Humans</subject><subject>Liver Neoplasms - diagnostic imaging</subject><subject>Male</subject><subject>Membrane Glycoproteins</subject><subject>Organometallic Compounds</subject><subject>Positron Emission Tomography Computed Tomography</subject><subject>Radiopharmaceuticals</subject><issn>0363-9762</issn><issn>1536-0229</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNqFkE1rGzEQhkVpaZy0_6AUHXvZRBrt6uOYurFjcKlpbHpctPLI3mQ_XElL6L_vGieh9NAKhAb0vDPMQ8gHzi45M-rq-3Jzyf44YABekQkvhMwYgHlNJkxIkRkl4Yycx3jPGJdc5m_JmeBGqVzpCblfhbq14Re9xYNNvcOmGRob6NQGV3d9a-mPOu3pokvYRaRSz222uvt6TTeHZB-Qfh4SvWvq3T5RrmfZ7Mv8-afv6OpmfTVd00Vrd3W3e0feeNtEfP_0XpDN7GY9vc2W3-aL6fUyc2AUZNrrHCvutc_VFo21knvwHACll86JLSJ4WbDC8WKLIPKqqoQG47xhTkoQF-TTqe8h9D8HjKls63hczHbYD7EcI0XBtFJqRPMT6kIfY0BfHk46Ss7Ko-VytFz-bXmMfXyaMFQtbl9Cz1pHQJ-Ax75JGOJDMzxiKPdom7T_X-_8H9EjJthoCRgcK8ay8eZS_AZn2paq</recordid><startdate>20200301</startdate><enddate>20200301</enddate><creator>Erhamamci, Seval</creator><creator>Aslan, Nesrin</creator><general>Lippincott Williams & Wilkins</general><general>Copyright Wolters Kluwer Health, Inc. All rights reserved</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20200301</creationdate><title>Primary Hepatocellular Carcinoma With Intense 68Ga-PSMA Uptake But Slight 18F-FDG Uptake on PET/CT Imaging</title><author>Erhamamci, Seval ; Aslan, Nesrin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2972-8f84eb1f8f47de9aa61f2f122e6f6cc3dee2f6505c15de234bbb3829cf90c6623</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Aged</topic><topic>Carcinoma, Hepatocellular - diagnostic imaging</topic><topic>Fluorodeoxyglucose F18</topic><topic>Humans</topic><topic>Liver Neoplasms - diagnostic imaging</topic><topic>Male</topic><topic>Membrane Glycoproteins</topic><topic>Organometallic Compounds</topic><topic>Positron Emission Tomography Computed Tomography</topic><topic>Radiopharmaceuticals</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Erhamamci, Seval</creatorcontrib><creatorcontrib>Aslan, Nesrin</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical nuclear medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Erhamamci, Seval</au><au>Aslan, Nesrin</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Primary Hepatocellular Carcinoma With Intense 68Ga-PSMA Uptake But Slight 18F-FDG Uptake on PET/CT Imaging</atitle><jtitle>Clinical nuclear medicine</jtitle><addtitle>Clin Nucl Med</addtitle><date>2020-03-01</date><risdate>2020</risdate><volume>45</volume><issue>3</issue><spage>e176</spage><epage>e177</epage><pages>e176-e177</pages><issn>0363-9762</issn><eissn>1536-0229</eissn><abstract>ABSTRACTGa-PSMA PET/CT imaging is an emerging imaging modality in prostate cancer. PSMA expression is also reported for nonprostate malignancies, including primary hepatocellular carcinoma. Herein, we present a case of a 74-year-ald man with recently diagnosed hepatocellular carcinoma who was referred for F-FDG PET/CT imaging for initial staging. The patient underwent F-FDG PET/CT as part of staging procedure; he also underwent Ga-PSMA PET/CT. PET/CT images revealed only slight F-FDG uptake in the liver lesion, but intense Ga-PSMA uptake, without any metastatic lesion seen elsewhere in the body.</abstract><cop>United States</cop><pub>Lippincott Williams & Wilkins</pub><pmid>31977478</pmid><doi>10.1097/RLU.0000000000002922</doi></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0363-9762 |
ispartof | Clinical nuclear medicine, 2020-03, Vol.45 (3), p.e176-e177 |
issn | 0363-9762 1536-0229 |
language | eng |
recordid | cdi_proquest_miscellaneous_2345508777 |
source | HEAL-Link subscriptions: Lippincott Williams & Wilkins |
subjects | Aged Carcinoma, Hepatocellular - diagnostic imaging Fluorodeoxyglucose F18 Humans Liver Neoplasms - diagnostic imaging Male Membrane Glycoproteins Organometallic Compounds Positron Emission Tomography Computed Tomography Radiopharmaceuticals |
title | Primary Hepatocellular Carcinoma With Intense 68Ga-PSMA Uptake But Slight 18F-FDG Uptake on PET/CT Imaging |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T06%3A18%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Primary%20Hepatocellular%20Carcinoma%20With%20Intense%2068Ga-PSMA%20Uptake%20But%20Slight%2018F-FDG%20Uptake%20on%20PET/CT%20Imaging&rft.jtitle=Clinical%20nuclear%20medicine&rft.au=Erhamamci,%20Seval&rft.date=2020-03-01&rft.volume=45&rft.issue=3&rft.spage=e176&rft.epage=e177&rft.pages=e176-e177&rft.issn=0363-9762&rft.eissn=1536-0229&rft_id=info:doi/10.1097/RLU.0000000000002922&rft_dat=%3Cproquest_cross%3E2345508777%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c2972-8f84eb1f8f47de9aa61f2f122e6f6cc3dee2f6505c15de234bbb3829cf90c6623%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2345508777&rft_id=info:pmid/31977478&rfr_iscdi=true |